12/16
08:00 am
wint
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
Medium
Report
Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference
12/9
08:15 am
wint
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia [Yahoo! Finance]
Low
Report
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia [Yahoo! Finance]
12/9
08:00 am
wint
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
Low
Report
Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia
12/4
08:12 am
wint
Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction [Yahoo! Finance]
High
Report
Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction [Yahoo! Finance]
12/4
08:09 am
wint
Windtree Therapeutics, Inc. (NASDAQ: WINT) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
High
Report
Windtree Therapeutics, Inc. (NASDAQ: WINT) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.
12/4
08:00 am
wint
Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction
High
Report
Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction
11/27
04:10 pm
wint
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates [Yahoo! Finance]
Medium
Report
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates [Yahoo! Finance]
11/27
04:05 pm
wint
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
High
Report
Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates
11/14
08:12 am
wint
Windtree Announces Leadership Transition Plan With Industry Veterans [Yahoo! Finance]
Medium
Report
Windtree Announces Leadership Transition Plan With Industry Veterans [Yahoo! Finance]
11/14
08:00 am
wint
Windtree Announces Leadership Transition Plan With Industry Veterans
Medium
Report
Windtree Announces Leadership Transition Plan With Industry Veterans
11/4
08:00 am
wint
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong
Medium
Report
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong Kong
10/30
08:00 am
wint
Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3
High
Report
Windtree Therapeutics Initiates SEISMiC C Study of Istaroxime in SCAI Stage C Cardiogenic Shock for Planned Completion of Phase 2b and Transition to Phase 3
10/23
08:00 am
wint
Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World
Medium
Report
Windtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the World
10/21
08:00 am
wint
Windtree To Present at the ThinkEquity Conference on October 30th
Low
Report
Windtree To Present at the ThinkEquity Conference on October 30th
10/17
08:18 am
wint
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan [Yahoo! Finance]
High
Report
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan [Yahoo! Finance]
10/17
08:15 am
wint
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan
High
Report
Windtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Japan
10/14
04:20 pm
wint
WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones [Yahoo! Finance]
Low
Report
WINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected Milestones [Yahoo! Finance]
10/9
08:00 am
wint
Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design
High
Report
Windtree Announces Publication of Positive Istaroxime Phase 2b Study Trial Design
9/30
08:15 am
wint
Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock
High
Report
Windtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic Shock
9/26
04:05 pm
wint
Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET
Medium
Report
Windtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ET
9/25
08:15 am
wint
Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock
Medium
Report
Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic Shock